Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Results of a prospective placebo-controlled double-blind trial

Restricted access

✓ With the cooperation of 60 neurosurgical centers in Japan, a prospective randomized placebo-controlled double-blind trial of a new calcium antagonist AT877 (hexahydro-1-(5-isoquinolinesulfonyl)-1H-1,4-diazepine hydrochloride, or fasudil hydrochloride) was undertaken to determine the drug's effect on delayed cerebral vasospasm in patients with a ruptured cerebral aneurysm. A total of 276 patients, who underwent surgery within 3 days after subarachnoid hemorrhage (SAH) of Hunt and Hess Grades I to IV, were entered into the study. Nine patients were excluded because of protocol violation. The remaining 267 patients received either 30 mg AT877 or a placebo (saline) by intravenous injection over 30 minutes, three times a day for 14 days following surgery. Demographic and clinical data were well matched between the two groups.

It was found that AT877 reduced angiographically demonstrable vasospasm by 38% (from 61% in the placebo group to 38% in the AT877 group, p = 0.0023), low-density regions on computerized tomography associated with vasospasm by 58% (from 38% to 16%, p = 0.0013), and symptomatic vasospasm by 30% (from 50% to 35%, p = 0.0247). Furthermore, AT877 reduced the number of patients with a poor clinical outcome associated with vasospasm (moderate disability or worse on the Glasgow Outcome Scale at 1 month after SAH) by 54% (from 26% to 12%, p = 0.0152). There were no serious adverse events reported in the AT877 group. This is the first report of a placebo-controlled double-blind trial that has demonstrated a significant reduction in angiographically revealed vasospasm by intravenous drug therapy.

Article Information

Contributor Notes

Address reprint requests to: Masato Shibuya, M.D., Department of Neurosurgery, Nagoya University, 466 Nagoya, Japan.

© AANS, except where prohibited by US copyright law.

Headings
References
  • 1.

    Allen GSAhn HSPreziosi TJet al: Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:6196241983Allen GS Ahn HS Preziosi TJ et al: Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619–624 1983

    • Search Google Scholar
    • Export Citation
  • 2.

    Asano TIkegaki ISatoh Set al: Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:3653721990Asano T Ikegaki I Satoh S et al: Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:365–372 1990

    • Search Google Scholar
    • Export Citation
  • 3.

    Asano TIkegaki ISatoh Set al: Mechanism of action of a novel antivasospasm drug, HA 1077. J Pharmacol Exp Ther 241:103310401987Asano T Ikegaki I Satoh S et al: Mechanism of action of a novel antivasospasm drug HA 1077. J Pharmacol Exp Ther 241:1033–1040 1987

    • Search Google Scholar
    • Export Citation
  • 4.

    Asano TSuzuki TTsuchiya Met al: Vasodilator actions of HA 1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98:109111001989Asano T Suzuki T Tsuchiya M et al: Vasodilator actions of HA 1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98:1091–1100 1989

    • Search Google Scholar
    • Export Citation
  • 5.

    Auer LMSchneider GHAuer T: Computerized tomography and prognosis in early aneurysm surgery. J Neurosurg 65:2172211986Auer LM Schneider GH Auer T: Computerized tomography and prognosis in early aneurysm surgery. J Neurosurg 65:217–221 1986

    • Search Google Scholar
    • Export Citation
  • 6.

    Espinosa FWeir BOverton Tet al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg 60:116711751984Espinosa F Weir B Overton T et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg 60:1167–1175 1984

    • Search Google Scholar
    • Export Citation
  • 7.

    Findlay JMWeir BKASteinke Det al: Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69:7237351988Findlay JM Weir BKA Steinke D et al: Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69:723–735 1988

    • Search Google Scholar
    • Export Citation
  • 8.

    Fisher CMKistler JPDavis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:191980Fisher CM Kistler JP Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9 1980

    • Search Google Scholar
    • Export Citation
  • 9.

    Frazee JGBevan JABevan RDet al: Effect of diltiazem on experimental chronic cerebral vasospasm in the monkey. J Neurosurg 62:9129171985Frazee JG Bevan JA Bevan RD et al : Effect of diltiazem on experimental chronic cerebral vasospasm in the monkey. J Neurosurg 62:912–917 1985

    • Search Google Scholar
    • Export Citation
  • 10.

    Gotoh OMohamed AAMcCulloch Jet al: Nimodipine and the haemodynamic and histopathological consequence of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6:3213311986Gotoh O Mohamed AA McCulloch J et al: Nimodipine and the haemodynamic and histopathological consequence of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6:321–331 1986

    • Search Google Scholar
    • Export Citation
  • 11.

    Haley ECTorner JCKassell NFet al: Cooperative randomized study of nicardipine in subarachnoid hemorrhage: preliminary report in Sano KTakakura KKassell NFet al (eds): Cerebral Vasospasm. Tokyo: University of Tokyo Press1990 pp 519525Haley EC Torner JC Kassell NF et al: Cooperative randomized study of nicardipine in subarachnoid hemorrhage: preliminary report in Sano K Takakura K Kassell NF et al (eds): Cerebral Vasospasm. Tokyo: University of Tokyo Press 1990 pp 519–525

    • Search Google Scholar
    • Export Citation
  • 12.

    Hidaka HInagaki MKawamoto Set al: Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:503650411984Hidaka H Inagaki M Kawamoto S et al: Isoquinolinesulfonamides novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036–5041 1984

    • Search Google Scholar
    • Export Citation
  • 13.

    Hunt WEHess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14201968Hunt WE Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20 1968

    • Search Google Scholar
    • Export Citation
  • 14.

    Jan MBuchheit FTremoulet M: Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 23:1541571988Jan M Buchheit F Tremoulet M: Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 23:154–157 1988

    • Search Google Scholar
    • Export Citation
  • 15.

    Jennett BBond MR: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:4804841975Jennett B Bond MR: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484 1975

    • Search Google Scholar
    • Export Citation
  • 16.

    Kassell NFSasaki TColohan ARTet al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:5625721985Kassell NF Sasaki T Colohan ART et al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562–572 1985

    • Search Google Scholar
    • Export Citation
  • 17.

    Kassell NFTorner JCHaley EC Jret al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18361990Kassell NF Torner JC Haley EC Jr et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18–36 1990

    • Search Google Scholar
    • Export Citation
  • 18.

    Krueger CWeir BNosko Met al: Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm. Neurosurgery 16:1371401985Krueger C Weir B Nosko M et al: Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm. Neurosurgery 16:137–140 1985

    • Search Google Scholar
    • Export Citation
  • 19.

    Ljunggren BBrandt LSäveland Het al: Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg 61:8648731984Ljunggren B Brandt L Säveland H et al: Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg 61:864–873 1984

    • Search Google Scholar
    • Export Citation
  • 20.

    Mee EDorrance DLowe Det al: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22:4844911988Mee E Dorrance D Lowe D et al: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22:484–491 1988

    • Search Google Scholar
    • Export Citation
  • 21.

    Nosko MWeir BKrueger Cet al: Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Neurosurgery 16:1291361985Nosko M Weir B Krueger C et al: Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Neurosurgery 16:129–136 1985

    • Search Google Scholar
    • Export Citation
  • 22.

    Öhman JHeiskanen O: Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:6836861988Öhman J Heiskanen O: Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:683–686 1988

    • Search Google Scholar
    • Export Citation
  • 23.

    Petruk KCWest MMohr Get al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:5055171988Petruk KC West M Mohr G et al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505–517 1988

    • Search Google Scholar
    • Export Citation
  • 24.

    Philippon JGrob RDagreou Fet al: Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 82:1101141986Philippon J Grob R Dagreou F et al: Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 82:110–114 1986

    • Search Google Scholar
    • Export Citation
  • 25.

    Pickard JDMurray GDIllingworth Ret al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. Br Med J 298:6366421989Pickard JD Murray GD Illingworth R et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. Br Med J 298:636–642 1989

    • Search Google Scholar
    • Export Citation
  • 26.

    Schanne FAXKane ABYoung EEet al: Calcium dependence of toxic cell death: a final common pathway. Science 206:7007021979Schanne FAX Kane AB Young EE et al: Calcium dependence of toxic cell death: a final common pathway. Science 206:700–702 1979

    • Search Google Scholar
    • Export Citation
  • 27.

    Seifert VEisert WGStolke Det al: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25:5905981989Seifert V Eisert WG Stolke D et al: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25:590–598 1989

    • Search Google Scholar
    • Export Citation
  • 28.

    Shibuya MSuzuki YSugita Ket al: Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir 107:11151990Shibuya M Suzuki Y Sugita K et al: Dose escalation trial of a novel calcium antagonist AT877 in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir 107:11–15 1990

    • Search Google Scholar
    • Export Citation
  • 29.

    Shibuya MSuzuki YTakayasu Met al: The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs. Acta Neurochir 90:53591988Shibuya M Suzuki Y Takayasu M et al: The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs. Acta Neurochir 90:53–59 1988

    • Search Google Scholar
    • Export Citation
  • 30.

    Takayasu MSuzuki YShibuya Met al: The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 65:80851986Takayasu M Suzuki Y Shibuya M et al: The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg 65:80–85 1986

    • Search Google Scholar
    • Export Citation
  • 31.

    Zabramski JSpetzler RFBonstelle C: Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery 18:1291351986Zabramski J Spetzler RF Bonstelle C: Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery 18:129–135 1986

    • Search Google Scholar
    • Export Citation
TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 337 332 23
Full Text Views 273 161 4
PDF Downloads 139 82 4
EPUB Downloads 0 0 0
PubMed
Google Scholar